tiprankstipranks
Trending News
More News >
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market

Guided Therapeutics (GTHP) Ratios

Compare
28 Followers

Guided Therapeutics Ratios

GTHP's free cash flow for Q3 2025 was $0.13. For the 2025 fiscal year, GTHP's free cash flow was decreased by $ and operating cash flow was $-10.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.12 0.19 0.29 0.62 0.29
Quick Ratio
0.03 0.09 0.16 0.50 0.19
Cash Ratio
0.01 0.06 0.12 0.48 0.11
Solvency Ratio
-0.39 -0.37 -0.62 -0.68 -0.28
Operating Cash Flow Ratio
-0.17 -0.18 -0.36 -0.30 -0.28
Short-Term Operating Cash Flow Coverage
-0.49 -0.58 -1.34 -1.83 -1.40
Net Current Asset Value
$ -5.75M$ -5.07M$ -4.08M$ -3.25M$ -5.85M
Leverage Ratios
Debt-to-Assets Ratio
2.68 1.57 1.23 0.67 1.42
Debt-to-Equity Ratio
-0.43 -0.44 -0.54 -0.78 -0.53
Debt-to-Capital Ratio
-0.75 -0.79 -1.18 -3.65 -1.14
Long-Term Debt-to-Capital Ratio
-0.01 -0.01 -0.16 -0.64 -0.34
Financial Leverage Ratio
-0.16 -0.28 -0.44 -1.17 -0.37
Debt Service Coverage Ratio
-0.69 -0.84 -1.98 -2.65 -0.40
Interest Coverage Ratio
-3.87 -5.53 -12.44 -5.73 -2.05
Debt to Market Cap
0.11 0.23 0.23 0.20 0.32
Interest Debt Per Share
0.04 0.04 0.05 0.09 0.30
Net Debt to EBITDA
-1.19 -0.91 -0.47 0.01 -2.45
Profitability Margins
Gross Profit Margin
33.71%28.57%36.73%-523.08%24.69%
EBIT Margin
-1160.11%-29085.71%-3276.53%-28915.38%-1135.80%
EBITDA Margin
-1102.25%-27728.57%-3189.80%-28361.54%-1134.57%
Operating Profit Margin
-1233.15%-30114.29%-3527.55%-25638.46%-2916.05%
Pretax Profit Margin
-1478.65%-34528.57%-3560.20%-33392.31%-2555.56%
Net Profit Margin
-1478.65%-34528.57%-3560.20%-33392.31%-2555.56%
Continuous Operations Profit Margin
-1478.65%-34528.57%-3560.20%-33392.31%-2555.56%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
119.91%114.66%100.93%130.24%87.64%
Return on Assets (ROA)
-291.47%-175.40%-209.05%-128.97%-101.47%
Return on Equity (ROE)
69.56%49.44%91.67%150.57%38.02%
Return on Capital Employed (ROCE)
39.43%44.13%110.10%221.76%64.64%
Return on Invested Capital (ROIC)
68.00%77.22%197.77%541.95%96.53%
Return on Tangible Assets
-291.47%-175.40%-209.05%-128.97%-101.47%
Earnings Yield
-12.88%-28.10%-44.45%-44.52%-26.68%
Efficiency Ratios
Receivables Turnover
29.67 2.33 14.00 2.17 1.76
Payables Turnover
0.05 <0.01 0.03 0.04 0.02
Inventory Turnover
0.20 <0.01 0.10 0.15 0.11
Fixed Asset Turnover
2.05 0.04 0.38 0.04 0.21
Asset Turnover
0.20 <0.01 0.06 <0.01 0.04
Working Capital Turnover Ratio
-0.03 >-0.01 -0.04 >-0.01 -0.01
Cash Conversion Cycle
-5.55K -109.12K -8.16K -7.39K -11.03K
Days of Sales Outstanding
12.30 156.43 26.07 168.46 207.28
Days of Inventory Outstanding
1.80K 46.21K 3.72K 2.47K 3.42K
Days of Payables Outstanding
7.37K 155.49K 11.91K 10.03K 14.65K
Operating Cycle
1.82K 46.37K 3.75K 2.64K 3.62K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.01 -0.02 -0.03 -0.05 -0.12
Free Cash Flow Per Share
-0.01 -0.02 -0.03 -0.05 -0.12
CapEx Per Share
<0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
-5.31 -6.43 0.00 -47.68 -113.71
Capital Expenditure Coverage Ratio
-554.50 0.00 0.00 -47.68 -113.71
Operating Cash Flow Coverage Ratio
-0.46 -0.52 -0.85 -0.65 -0.55
Operating Cash Flow to Sales Ratio
-6.23 -159.86 -17.82 -113.69 -19.65
Free Cash Flow Yield
-5.31%-13.01%-22.25%-15.47%-20.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.76 -3.56 -2.25 -2.25 -3.75
Price-to-Sales (P/S) Ratio
117.46 1.23K 80.09 750.12 95.79
Price-to-Book (P/B) Ratio
-3.62 -1.76 -2.06 -3.38 -1.42
Price-to-Free Cash Flow (P/FCF) Ratio
-18.82 -7.69 -4.50 -6.46 -4.83
Price-to-Operating Cash Flow Ratio
-18.42 -7.69 -4.50 -6.60 -4.87
Price-to-Earnings Growth (PEG) Ratio
-1.31 0.09 0.04 0.13 -0.01
Price-to-Fair Value
-3.62 -1.76 -2.06 -3.38 -1.42
Enterprise Value Multiple
-11.84 -5.34 -2.98 -2.63 -10.90
Enterprise Value
23.24M 10.37M 9.32M 9.70M 10.01M
EV to EBITDA
-11.84 -5.34 -2.98 -2.63 -10.90
EV to Sales
130.56 1.48K 95.06 746.27 123.64
EV to Free Cash Flow
-20.92 -9.27 -5.34 -6.43 -6.24
EV to Operating Cash Flow
-20.96 -9.27 -5.34 -6.56 -6.29
Tangible Book Value Per Share
-0.07 -0.09 -0.07 -0.09 -0.41
Shareholders’ Equity Per Share
-0.07 -0.09 -0.07 -0.09 -0.41
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.03 -0.04 -0.07 -0.13 -0.15
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.27 1.19 1.09 1.15 2.25
Research & Development to Revenue
2.71 75.14 2.33 5.92 0.85
SG&A to Revenue
9.04 185.29 30.58 231.31 26.81
Stock-Based Compensation to Revenue
1.90 17.14 18.43 106.23 2.81
Income Quality
0.42 0.46 0.50 0.34 0.77
Currency in USD